MMedication Read More GLP-1 Drugs and Kids: ‘Is It the Right Thing?’November 21, 2026 Weight loss injections are inching their way into elementary schools. New data presented at an obesity conference…
MMedication Read More China’s 630 million weight problem: First GLP-1 pill gets the green lightNovember 14, 2026 BEIJING, Nov 14 — China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to…
MMedication Read More Retatrutide Vs Ozempic: Double the Weight Loss, Different Side EffectsOctober 28, 2026 Gym bros call it “reta.” Eli Lilly is calling it the winner. On Wednesday, the pharmaceutical giant announced…
MMedication Read More Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policyOctober 27, 2026 ST. LOUIS, Mo. (First Alert 4) – Missouri Attorney General Catherine Hanaway announced Monday she has sent a…
MMedication Read More A New King of The GLP-1s Could Be Crowned – Cardiac WireOctober 5, 2026 A New King of The GLP-1s Could Be Crowned Cardiac Wire ‘Godzilla’ of weight-loss drugs could provide other important…
MMedication Read More Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 TrialOctober 4, 2026 An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
MMedication Read More Doctors condemn Eli Lilly move to dispense GLP-1 medication Mounjaro direct to doorSeptember 30, 2026 A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…
MMedication Read More Hundreds of lawsuits filed against some GLP-1 Makers over vision lossSeptember 22, 2026 Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
HHealth care Read More Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?August 31, 2026 Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
HHealth care Read More AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?August 30, 2026 The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether…